Stockreport

AIM ImmunoTech GAAP EPS of -$1.57 misses by $0.59 [Seeking Alpha]

AIM ImmunoTech Inc.  (AIM) 
PDF Research and development expenses for the three months ended September 30, 2025, were approximately $607,000, compared to $1.4 million for the same period in 2024. Ge [Read more]